Pooled polyvalent sera from lepromatous leprosy patients were used to screen a Agtll recombinant DNA expression library of Mycobacterium leprae in order to identify the relevant antigens recognized by the human immune response. Of the 300,000 phages screened, 4 clones were identified that coded for fusion proteins of the same molecular mass. The fusion protein from clone LSR2 was tested for immunoreactivity in assays using peripheral blood cells and sera from 11 laboratory personnel and 105 patients across the leprosy spectrum. LSR2 protein appears to be predominantly a T-cell antigen. It evokes similar lymphoproliferative responses as the native bacillus both at the individual level and in the leprosy spectrum as a whole. Though only 50% of patient sera with anti-M. leprae antibodies reacted with the fusion protein, the pattern of reactivity in the antibody responses was also similar for the various clinical types. The coding regions of clones LSR1 and LSR2 are identical. They show no homology with sequences stored in data banks and encode a protein of 89 amino acids with a calculated molecular mass of -10 kDa.
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Leprosy is a chronic infectious disease caused by noncultivable Mycobacterium leprae. The clinicopathological spectrum observed in this disease reflects the variability in the host immune responses to the pathogen (1) . Protective immunity is mainly effected by cellular responses as evidenced by the presence of optimal T-cell functions in the localized paucibacillary form of tuberculoid (TT) leprosy. In contrast, the generalized multibacillary lepromatous (LL) leprosy shows antigen-specific T-cell anergy concomitant with the presence of high levels of specific and crossreactive mycobacterial antibodies (2, 3) . Young et al. (4) constructed a genomic library of M. leprae in the Agtll expression vector. By using monoclonal antibodies (mAbs) as screening reagents, genes coding for 12-, 18-, 28-, 36-, and 65-kDa proteins of M. leprae were identified. Whereas some of these have been shown to share homology with the heat shock proteins of various species (5) (6) (7) (8) , the 18-kDa protein has been found to be stimulatory for human T helper clones (9) and for peripheral blood cells from healthy contacts (10) .
With a view to identifying genes expressing proteins recognized by the human immune response to natural M. leprae infection, we have used polyclonal antibodies obtained from pooled sera of lepromatous patients to screen the Agtll DNA expression library. We have identified four clones coding for a fusion protein of the same molecular mass. § It appears to be a dominant T-cell antigen and mimics the native bacillus in lymphoproliferative responses of all clinical types of leprosy patients. It is also recognized by the sera of 50-70o of the patients having anti-M. leprae antibodies.
MATERIALS AND METHODS
Subjects. The study included 105 leprosy patients attending the Hansen disease clinic of Safdarjung Hospital (New Delhi) and 11 healthy laboratory personnel with >3 years of constant contact with patients. The type of leprosy was diagnosed on the basis of clinical and histopathological criteria of Ridley and Jopling (11) , and the bacterial index was assessed by slit skin smears. Patients were bled prior to or within 6 months of treatment with a multidrug regimen consisting of 600 mg of rifampicin monthly, 100 mg of clofazimine on alternate days, and 100 mg of dapsone daily.
Sera. Sera from untreated LL patients were screened for the presence of anti-M. leprae antibodies by a dot ELISA using sonicated M. leprae as antigen [leprosin, 10 ,g/ml; courtesy of R. J. W. Characterization of the Recombinant LSR Proteins. Lysogens of LSR clones were established in E. coli Y1089 and induced to produce recombinant proteins, as described (12) . Lysates thus obtained were subjected to SDS/8% PAGE (15) followed by Western blot analysis (16) using the pooled LL sera or anti-f3-galactosidase mAb (Promega). DNA Hybridization. Samples (2 ,ul) tTo whom reprint requests should be addressed. §The sequence reported in this paper has been deposited in the GenBank data base (accession no. X53487).
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. murine mAbs (courtesy of R. A. Young) that define the 28-, 65-, 18-, 36-, and 12-kDa antigens, respectively, and Agtll (without insert) were grown on a lawn of E. coli Y1090. Bacteriophage DNA was transferred onto NCP, denatured (1.5 M NaCl/0.5 M NaOH), and neutralized (1.5 M NaCl/0.5 M Tris-HCI, pH 8.0), and the dried filters were baked at 80'C for 2 hr. Phage DNA from the above clones was cut with EcoRI (New England Biolabs), and the fragments were separated by electrophoresis in 0.8% agarose gel (type 2, Sigma) and subjected to Southern blot analysis (17) .
Purified and nick-translated insert DNA from clone LSR2 was used to probe the plaque replica and the Southern blot.
Hybridizations were carried out at 420C for 16 hr in 50% (vol/vol) formamide/5 x SSC (lx SSC is 150 mM NaCl/15 mM trisodium citrate)/0.1% Ficoll/0.1% polyvinylpyrrolidone/0.1% bovine serum albumin/50 mM Tris HCI, pH 7.5, containing sonicated salmon sperm DNA at 250 gg/ml.
Washing was done sequentially in 2x SSC/0.1% SDS for 20 min, with two changes, at room temperature, followed by 2x SSC/0. 1% SDS at 500C for 30 min and finally 0.1 x SSC/0. 1% SDS at 64°C for 30 min. The blots were then exposed to polyester x-ray films (Hindustan Photo Films Manufacturing, Udhagamandalan, India) for 16 hr at -70°C.
M. leprae Antigens. Armadillo-derived M. leprae (courtesy of R. J. W. Rees through the IMMLEP Program of WHO) was used as integral and sonicated form for the lymphoproliferation assay and dot ELISA, respectively. Except where stated 5 x 106 bacilli per ml and 10 and 20 ng of leprosin were used. The expressed recombinant proteins were isolated from lysates of E. coli Y1089 lysogenized with LSR2 and tested at concentrations indicated below. Thirty microliters of lysate (1 mg/ml) of LSR2 lysogen was resolved by SDS/ PAGE and transferred to NCP. The fusion protein band identified in a position complementary to the Western blot was cut out and converted into antigen-bearing particles by dissolution in dimethyl sulfoxide, precipitation with carbonate/bicarbonate buffer (pH 9.6), and resuspension in 1 ml of medium RPMI 1640 (GIBCO) (18) . A P3-galactosidase band, obtained from lysates of E. coli Y1089 lysogenized with Agtll, and a piece of NCP of similar size were treated in an identical manner for use as controls.
Lymphoproliferation Assays. Ficoll/Hypaque-separated (19) Antibody Assays. Sera from 11 healthy contacts and from 38 TT-BT, 9 BB, and 34 BL-LL patients were depleted of anti-E. coli antibodies and tested in a dot ELISA to detect antibodies to LSR2 protein. Samples (2 ,ul) containing 0. 4-1.6 ,ug of total protein from lysates of uninduced LSR2, induced LSR2, or induced Agtll (producing f3-galactosidase, negative control) lysogens or 10 and 20 ng ofleprosin (positive control) were dotted on NCP. Sera from healthy contacts and TT-BT patients were used at dilutions of 1:25 to 1:200; sera from BL-LL patients were tested at 1:150 and 1:300. Sera were considered positive when an unequivocal color reaction developed in the concentration range of the LSR2 protein used.
DNA Sequence Analysis. DNAs from clones LSR1 and -2 were prepared by standard methods and cloned separately into pBluescript (Stratagene) (17) . The insert DNA was isolated on low-melting-point agarose after digestion with EcoRI. The EcoRI fragment from LSR1 and the smaller EcoRI-Pst I fragment from LSR2 were subcloned into M13mpl8 or M13mpl9 (Bethesda Research Laboratories) as suggested by the supplier. DNA sequence was determined in both directions by the dideoxy chain-termination method (20) using universal primers. Band compressions due to secondary structures were resolved using Taq polymerase (Sequenase, United States Biochemical) and the primer extension method. Sequence data were analyzed using IBI/Pustell sequence-analysis programs and the amino acid sequence was inferred.
Statistical Analysis. The correlation coefficient for optimal responses to M. leprae and LSR2 protein was estimated by Spearman's rank correlation (21) . sorbed LL sera selected on the basis of high antibody levels to sonicated M. leprae. Four clones (LSR1, -2, -4, and -5) were identified. In contrast, pooled sera from TT patients failed to give unequivocal signals. All four clones produced a 135-kDa protein that reacted with LL sera (Fig. 1A) but not with pooled sera from TT patients or with mAbs directed against 65-and 18-kDa antigens of M. leprae. That these sera and mAbs were immunoreactive was indicated by positive reaction with the appropriate controls in a dot ELISA ( Table  1 ). The 135-kDa protein reacted with a mAb directed against 13-galactosidase (Fig. 1B) and was present only in induced cultures (lanes a), indicating that it was a fusion protein.
RESULTS
EcoRI digestion of LSR1 DNA yielded an insert of800 base pairs (bp) whereas LSR2, -4, and -5 had inserts of about 2.8 kilobase pairs (kb) (Fig. 2B) . The nick-translated EcoRI fragment from LSR2 hybridized strongly with phage DNA from all four clones ( Fig. 2A) . It did not hybridize with DNA from the control Agtll or with the five earlier reported clones identified with murine mAbs (4 creased from the TT to the LL pole. Only 2 of 11 healthy contacts had detectable levels of LSR2 antibodies (Fig. 4) . Thus it appears that in leprosy patients the pattern of antibody response to the recombinant protein closely follows that observed with sonicated native M. leprae. DNA Sequence Analysis. To further define the LSR clones insert DNA from the LSR1 and LSR2 clones was sequenced according to the strategy shown in HC (11) TT-BT (38) BB (9) FIG . frame extending from the EcoRI site was found that coded for the same 89 amino acids in both clones ( 
DISCUSSION
With a view to identifying the dominant protein antigens recognized by the human immune response to natural M. leprae infection, we used preadsorbed polyvalent sera from LL patients to screen the Agtll DNA expression library ofM. leprae. Four clones were identified that coded for a lacZ promoter-dependent fusion protein of the same molecular mass. Clone LSR1 had an 800-bp insert, whereas the other clones had inserts of about 2.8 kb. With the LSR2 insert as a probe, hybridization was shown to be uniquely restricted to LSR clones, with no detectable homology to phage DNA derived from the five previously reported clones identified by murine antibodies (4, 13) . That the recombinant protein does not correspond to any of the known stress proteins is indicated by the hybridization data.
To evaluate the immunoreactivity of the fusion protein, lysates from clone LSR2 were tested in lymphoproliferation assays using PBMCs from patients across the leprosy spectrum as well as control healthy responders who had been exposed to M. leprae. Significantly, there was marked similarity in the lymphoproliferative responses to the fusion protein and the native integral bacilli both at the individual level and for the clinical type of leprosy. Maximal lymphoproliferative responses were observed for the healthy and BT-TT leprosy subjects, with a marked decline in responsiveness for the BB erative response observed with the native antigen appears to be contributed by the antigen represented in the fusion protein.
Previous studies on recombinant proteins from the same library had used T-cell lines and clones to study immunoreactivity (9, 23, 24) . These may not truly reflect the antigens relevant to the biology of the disease or the total T-cell repertoire, since not all T cells may have survived the in vitro selection pressures inherent in the current methodologies. Similar to the present report, Dockrell et al. (10) also used unfractionated PBMCs of leprosy patients and healthy contacts for studying T-cell responses to another recombinant protein of M. leprae, which has been shown to be an 18-kDa stress protein. They found that 50% of tuberculoid patients and 95% of healthy contacts showed lymphoproliferation to this antigen. Our LSR2 protein stimulated lymphoproliferation of a higher proportion (90%) of BT-TT patients and healthy contacts.
In antibody assays the LSR2 protein was recognized by only half of the leprosy patient sera having detectable levels ofantibodies to sonicated M. leprae. However, the pattern of reactivity in the clinical groups was similar for both antigens in that the number of patients with antibodies was lowest at the Ti pole and increased towards the LL pole. Though the recombinant protein had been selected on the basis of reactivity with pooled LL sera having mycobacterial antibodies, at the individual patient level the reactivity was limited. This suggests that the humoral response to LSR2 may reflect individual variation in antibody profiles. Alternatively, the sonicated antigen is likely to have a larger number of epitopes of both specific and crossreactive types. The lower-thanexpected antibody reactivity in patients appears to be common to many recombinant proteins of M. leprae (25, 26) .
In both the LSR1 and the LSR2 clone, an open reading frame extending from the EcoRI site was identified that coded for 89 amino acids with a calculated molecular mass of -10 kDa. With the 114 kDa for the truncated P-galactosidase encoded in Agt11, the fusion protein would be 124 kDa. Within the limitations in estimating molecular mass from mobilities in SDS/polyacrylamide gels, this compares well with 135-kDa fusion protein detected in the Western blots.
The nature of the gene coding for this protein is not known, as a search in the sequence banks did not reveal significant homology with any known gene or protein, including the 18-, 28-, 36-, 65-, and 70-kDa protein identified recently (8, (27) (28) (29) (30) . It does not appear to have sequences reminiscent of signal peptides (31) , nor does it share homology with the 28-kDa recombinant protein identified by Cherayil and Young (32) using lepromatous sera. Sathish et al. (33) recently detected 45 recombinant clones with leprosy patients sera whose further characterization is awaited.
The recombinant protein identified by us mimics the native M. leprae in T-cell responses across the leprosy spectrum.
Such mimicry would be amenable to exploitation for understanding the protective immune mechanisms in leprosy. Moreover, the responder individuals showing T-cell reactivity to LSR2 protein were unrelated, indicating that major histocompatibility complex (MHC) restriction did not apply to the molecule as a whole. Such permissive MHC association has been reported for malarial peptides (34) and may be ofadvantage in designing vaccines. It appears that polyvalent sera from patients are useful for identifying recombinant proteins of relevance to human T-cell responses.
